FGEN

FibroGen News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 40.17 08:49:44
Open Price Low Price High Price Close Price Previous Close
40.17
more quote information »

Recent News

Date Time Source Heading
11/27/202007:00GLOBEAstellas Receives Approval of EVRENZO® (roxadustat) in Japan..
11/27/202002:02PRNUSAstellas Receives Approval of EVRENZO® (roxadustat) in Japan..
11/19/202016:52EDGARStatement of Changes in Beneficial Ownership (4)
11/12/202016:47EDGARCurrent Report Filing (8-k)
11/06/202007:00GLOBEFibroGen to Present at Upcoming Investor Conferences
11/05/202016:15EDGARQuarterly Report (10-q)
11/05/202016:08EDGARCurrent Report Filing (8-k)
11/05/202016:01GLOBEFibroGen Reports Third Quarter 2020 Financial Results
10/29/202007:00GLOBEFibroGen to Report Third Quarter 2020 Financial Results
10/22/202010:08GLOBEFibroGen Presents Late-Breaker Abstract Results on..
10/14/202007:00GLOBEFibroGen to Present New Efficacy and Safety Analyses from..
10/02/202007:00PRNUSNew Ventures Funds Rebrands as Scientia Ventures
9/18/202017:19EDGARStatement of Changes in Beneficial Ownership (4)
9/17/202018:04EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:36EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:33EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:30EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:28EDGARStatement of Changes in Beneficial Ownership (4)
9/08/202007:00GLOBEFibroGen Appoints Percy Carter, MBA, PhD, as Chief..
9/04/202016:34EDGARStatement of Changes in Beneficial Ownership (4)
9/04/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
9/01/202007:00GLOBEFibroGen to Present at Upcoming Investor Conferences
8/21/202017:59EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202016:35EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202007:00GLOBEFibroGen Announces First Patient Enrolled in Pamrevlumab..
8/07/202019:50EDGARStatement of Changes in Beneficial Ownership (4)
8/07/202019:46EDGARStatement of Changes in Beneficial Ownership (4)
8/07/202019:26EDGARInitial Statement of Beneficial Ownership (3)
8/06/202016:19EDGARQuarterly Report (10-q)
8/06/202016:12EDGARCurrent Report Filing (8-k)
8/06/202016:07EDGARCurrent Report Filing (8-k)
8/06/202016:02GLOBEFibroGen Reports Second Quarter 2020 Financial Results
8/06/202016:01GLOBEFibroGen Announces New Appointments to its Board of..
7/28/202019:34EDGARStatement of Changes in Beneficial Ownership (4)
7/23/202007:00GLOBEFibroGen to Report Second Quarter 2020 Financial Results
7/10/202017:01EDGARCurrent Report Filing (8-k)
6/23/202007:00GLOBEFibroGen Announces First Patient Enrolled in Pamrevlumab..
6/22/202007:00GLOBEFibroGen Appoints Thane Wettig as Chief Commercial Officer
6/18/202018:36EDGARStatement of Changes in Beneficial Ownership (4)
6/12/202007:00EDGARStatement of Changes in Beneficial Ownership (4)
6/09/202016:32EDGARCurrent Report Filing (8-k)
6/08/202017:00GLOBEFibroGen Announces New Roxadustat Data Presented at 2020..
6/08/202007:00GLOBEFibroGen Announces First Patient Enrolled in Pamrevlumab..
5/27/202007:00GLOBEFibroGen to Present at Upcoming Investor Conferences
5/21/202007:00GLOBEEuropean Medicines Agency Accepts Astellas’ Marketing..
5/20/202022:00PRNUSEuropean Medicines Agency Accepts Astellas' Marketing..
5/08/202007:00GLOBEFibroGen to Present at Bank of America Securities 2020..
5/07/202016:17EDGARQuarterly Report (10-q)
5/07/202016:13EDGARCurrent Report Filing (8-k)
5/07/202016:01GLOBEFibroGen Reports First Quarter 2020 Financial Results
See more news about this stock »
Your Recent History
NASDAQ
FGEN
FibroGen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 14:09:15